Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Miwako Ishido is active.

Publication


Featured researches published by Miwako Ishido.


Arthritis & Rheumatism | 2009

Retinoid ameliorates experimental autoimmune myositis, with modulation of Th cell differentiation and antibody production in vivo.

Naho Ohyanagi; Miwako Ishido; Fumihito Suzuki; Kayoko Kaneko; Tetsuo Kubota; Nobuyuki Miyasaka; Toshihiro Nanki

OBJECTIVE Polymyositis and dermatomyositis are chronic inflammatory muscle diseases. Retinoids are compounds that bind to the retinoic acid binding site of retinoic acid receptors and have biologic activities similar to those of vitamin A. Recent studies indicate that retinoids promote Th2 differentiation and suppress Th1 and Th17 differentiation in vitro. The present study was undertaken to examine the effects of a synthetic retinoid, Am80, on experimental autoimmune myositis as well as on Th phenotype development and antibody production. METHODS Experimental autoimmune myositis was induced in SJL/J mice by immunization with rabbit myosin. Am80 was administered orally once daily. Its effects were evaluated by measurement of the numbers of infiltrating inflammatory cells, production of inflammatory cytokines in muscle, production of Th-specific cytokines by myosin-stimulated splenic T cells, and production of antimyosin antibodies in serum. RESULTS In mice with experimental autoimmune myositis, orally administered Am80 significantly reduced the number of infiltrating inflammatory cells and the expression of tumor necrosis factor alpha and interleukin-1beta (IL-1beta) in muscle. Moreover, Am80 increased production of interferon-gamma, IL-4, and IL-10, but not IL-17, by myosin-stimulated splenic T cells of mice with experimental autoimmune myositis, suggesting that it could enhance differentiation into Th1 and Th2, but not Th17, in vivo. Am80 also decreased serum levels of IgG2a and IgG2b antimyosin antibodies, but did not affect levels of IgG1 antimyosin antibodies. In addition, it suppressed chemokine expression and activator protein 1 activity in myoblasts in vitro. CONCLUSION The synthetic retinoid Am80 has an inhibitory effect on experimental autoimmune myositis. It might regulate the development of Th phenotype and antibody production in vivo, in addition to its effects on cytokine and chemokine production.


Modern Rheumatology | 2010

The effect of synthetic retinoid, Am80, on T helper cell development and antibody production in murine collagen-induced arthritis

Aya Sato; Kaori Watanabe; Kayoko Kaneko; Yousuke Murakami; Miwako Ishido; Nobuyuki Miyasaka; Toshihiro Nanki


Archive | 2010

Medicament for Preventive and/or Therapeutic Treatment of Bowel Disease

Koichi Shudo; Hiroyuki Kagechika; Hiroshi Fukasawa; Tetsuro Matsuishi; Naoko Katsumura; Miwako Ishido


Archive | 2007

Medicament for preventive and/or therapeutic treatment of diseases with secretory disorder

Koichi Shudo; Tetsuro Matsuishi; Miwako Ishido


Archive | 2007

Pharmaceutical agent for prevention and/or treatment of inflammatory myopathy

Koichi Shudo; Miwako Ishido; Toshihiro Nanki; Nobuyuki Miyasaka


Archive | 2011

Use of 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2- naphthalenyl)carbamoyl]benzoic acid in preparing a pharmaceutical for use in prevention and/or treatment of bowel adhesion

Koichi Shudo; Hiroyuki Kagechika; Hiroshi Fukasawa; Tetsuro Matsuishi; Naoko Katsumura; Miwako Ishido


Archive | 2010

Method for treatment of adhesion of the intestines

Koichi Shudo; Hiroyuki Kagechika; Hiroshi Fukasawa; Tetsuro Matsuishi; Naoko Katsumura; Miwako Ishido


Archive | 2009

Method for treatment of inflammatory bowel disease

Koichi Shudo; Hiroyuki Kagechika; Hiroshi Fukasawa; Tetsuro Matsuishi; Naoko Katsumura; Miwako Ishido


Archive | 2008

Médicament pour prévenir et/ou traiter une fusion viscérale

Koichi Shudo; Naoko Katsumura; Miwako Ishido


Archive | 2008

Pharmaceutical agent for prevention and/or treatment of lower urinary tract symptom

Koichi Shudo; Tetsuji Asao; Miwako Ishido

Collaboration


Dive into the Miwako Ishido's collaboration.

Top Co-Authors

Avatar

Koichi Shudo

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Tetsuro Matsuishi

St. Marianna University School of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hiroyuki Kagechika

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Nobuyuki Miyasaka

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Toshihiro Nanki

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Kayoko Kaneko

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Aya Sato

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Fumihito Suzuki

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Kaori Watanabe

Tokyo Medical and Dental University

View shared research outputs
Researchain Logo
Decentralizing Knowledge